HCW Biologics Inc. Profile Avatar - Palmy Investing

HCW Biologics Inc.

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injecta…

Biotechnology
US, Miramar [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared HCW Biologics Inc. (HCWB) to it's peer group.

Peer Group
Loading...
End of HCWB's Analysis
CIK: 1828673 CUSIP: 40423R105 ISIN: US40423R1059 LEI: - UEI: -
Secondary Listings
HCWB has no secondary listings inside our databases.